Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>Mutations of the cyclin‐dependent kinase‐like 5 (<i>CDKL5</i>) gene cause severe neurodevelopmental disorders characterized by intractable epilepsy, intellectual disability, and autism. Multiple mouse models generated for mechanistic studies have exhibited phenotypes similar to some human pathological features, but none of the models has developed one of the major symptoms affecting CDKL5 deficiency disorder (CDD) patients: intractable recurrent seizures. As disrupted neuronal excitation/inhibition balance is closely associated with the activity of glutamatergic and γ‐aminobutyric acidergic (GABAergic) neurons, our aim was to study the effect of the loss of CDKL5 in different types of neurons on epilepsy. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Using the Cre‐LoxP system, we generated conditional knockout (cKO) mouse lines allowing CDKL5 deficiency in glutamatergic or GABAergic neurons. We employed noninvasive video recording and in vivo electrophysiological approaches to study seizure activity in these <i>Cdkl5</i> cKO mice. Furthermore, we conducted Timm staining to confirm a morphological alteration, mossy fiber sprouting, which occurs with limbic epilepsy in both human and mouse brains. Finally, we performed whole‐cell patch clamp in dentate granule cells to investigate cell‐intrinsic properties and synaptic excitatory activity. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>We demonstrate that Emx1‐ or CamK2α‐derived <i>Cdkl5</i> cKO mice manifest high‐frequency spontaneous seizure activities recapitulating the epilepsy of CDD patients, which ultimately led to sudden death in mice. However, <i>Cdkl5</i> deficiency in GABAergic neurons does not generate such seizures. The seizures were accompanied by typical epileptic features including higher amplitude spikes for epileptiform discharges and abnormal hippocampal mossy fiber sprouting. We also found an increase in spontaneous and miniature excitatory postsynaptic current frequencies but no change in amplitudes in the dentate granule cells of Emx1‐cKO mice, indicating enhanced excitatory synaptic activity. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Significance</h3><p>Our study demonstrates that <i>Cdkl5</i> cKO mice, serving as an animal model to study recurrent spontaneous seizures, have potential value for the pathological study of CDD‐related seizures and for therapeutic innovation. </p></section>

Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology

Novel CDKL5 targets identified in human iPSC-derived neurons

Enhanced hippocampal LTP but normal NMDA receptor and AMPA receptor function in a rat model of CDKL5 deficiency disorder

Loss of CDKL5 in Glutamatergic Neurons Disrupts Hippocampal Microcircuitry and Leads to Memory Impairment in Mice

Cell type-specific expression, regulation and compensation of CDKL5 activity in mouse brain

Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder–related deficits

CDKL5 deficiency in forebrain glutamatergic neurons results in recurrent spontaneous seizures

Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder

CDKL5's role in microtubule-based transport and cognitive function

Cdkl5, A Protein Associated With Rett Syndrome, Regulates Neuronal Morphogenesis Via Rac1 Signaling

The CDKL5 kinase undergoes liquid-liquid phase separation driven by a serine-rich C-terminal region and impaired by neurodevelopmental disease-related truncations

Neuroprotective Mechanisms Mediated by CDK5 Inhibition.

Altered network and rescue of human neurons derived from individuals with early-onset genetic epilepsy

CDKL5 Deficiency Disorder: Some Lessons Learned 20 Years After the First Description

Decreased Synapse‐associated Proteins Are Associated with the Onset of Epileptic Memory Impairment in Endothelial CDK5‐deficient Mice

Research progress on the pathogenesis of CDKL5 pathogenic variants and related encephalopathy

Cannabidiol attenuates seizure susceptibility and behavioural deficits in adult CDKL5R59X knock‐in mice

Systemic Administration of a Brain Permeable Cdk5 Inhibitor Alters Neurobehavior

Phosphoproteome and transcriptome analysis of the neuronal response to a CDK5 inhibitor

Neuronal hyperexcitability and ion channel dysfunction in CDKL5-deficiency patient iPSC-derived cortical organoids

Bacterial Production of CDKL5 Catalytic Domain: Insights in Aggregation, Internal Translation and Phosphorylation Patterns